What does CHRS company do? | Glauxie AI

Q: What does CHRS company do?

Coherus Oncology, Inc. (CHRS) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Dennis Lanfear. Coherus Oncology, Inc., a biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States. The company develops UDENYCA, a biosimilar to... Employees: 147.

Q: Who is the CEO of CHRS?

Find out who leads CHRS — CEO name, executive team, and compensation details.

Q: What sector is CHRS in?

Find CHRS sector, industry, and sub-industry classification with sector peer comparison.

Q: What are CHRS competitors?

Compare CHRS to its top competitors with side-by-side financials, valuation, and performance.

What does CHRS company do?

🦉

Coherus Oncology, Inc. (CHRS)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEODennis Lanfear

Coherus Oncology, Inc., a biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States. The company develops UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte-colony stimulating factor; LOQTORZI, a novel next-generation...

Key Executives

Name	Title
Andy Rittenberg	Chief Legal Officer
Arvind Sood	Chief Strategy & Corporate Affairs Officer
Bryan J. McMichael	Chief Financial Officer
Carrie Graham	Vice President of Investor Relations & Advocacy
Dennis Lanfear	Chairman, President & Chief Executive Officer
Michael Chen	Senior Vice President of Commercial Analytics & Trade

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

CHRS Profile Financials

Who is the CEO of CHRS? What sector is CHRS in? What are CHRS competitors?